TrialCancer science2020

Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment-free remission.

Takashi Kumagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.